Literature DB >> 2781613

Addisonian crisis induced by treatment with rifampicin.

E G Wilkins1, E Hnizdo, A Cope.   

Abstract

A patient with spinal tuberculosis and subclinical adrenal tuberculosis who developed acute Addisonian crisis on starting anti-tuberculosis therapy including rifampicin is reported. The possibility that many patients with tuberculosis have adrenal involvement with limited hormonal reserve and that they may develop incipient adrenal failure on commencing treatment is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2781613     DOI: 10.1016/0041-3879(89)90069-x

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  7 in total

Review 1.  The endocrinology of adrenal tuberculosis: the effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function.

Authors:  F Kelestimur
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

2.  Corticosteroids and tuberculosis.

Authors:  B J Heap
Journal:  BMJ       Date:  1991-11-09

3.  Rifampicin-induced adrenal crisis in a patient with tuberculosis: a therapeutic challenge.

Authors:  Nicholas Denny; Sarika Raghunath; Praveen Bhatia; Muntasir Abdelaziz
Journal:  BMJ Case Rep       Date:  2016-11-29

4.  Tuberculous Addison's disease with increased hydrocortisone requirements due to administration of rifampicin.

Authors:  Kazuhisa Kusuki; Satoshi Watanabe; Yuzo Mizuno
Journal:  BMJ Case Rep       Date:  2019-03-14

Review 5.  Endocrine and Metabolic Aspects of Tuberculosis.

Authors:  Christopher Vinnard; Emily A Blumberg
Journal:  Microbiol Spectr       Date:  2017-01

Review 6.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

7.  The Incidence and Risk Factors of Hyponatremia in Pulmonary Tuberculosis.

Authors:  Tomohiko Yoshida; Hidenori Masuyama; Hiroki Yamagata; Makoto Miyabayashi; Shunichiro Onishi; Yosuke Inaba; Minoru Takemoto
Journal:  J Endocr Soc       Date:  2022-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.